ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "S2E6 - Prothrombin Time routine does not mean "simple""
Episode Synopsis
Welcome to Ask Stago, The Podcast dedicated to provide expert answers to your expert questions in hemostasis.
In today episode, our expert Pierre Bourgeat, will discuss about the Prothrombin time reagent characteristics with a specific focus on the ISI and the type of activators.
As usual, don’t forget to send any question you may have to [email protected], we will be glad to answer to it.
To learn more:
Listen to our podcast about MNPT determination: #7 How to determine the mean normal prothrombin time
View the Webinar of Ian Jenning on stagowebinar.com
Literature:
Lusher, J. Screening and diagnosis of coagulation disorders. Am. J. Obstet. Gynecol. 1986; 175:778-783
Riley, R., Rowe, D., & Fisher, L. Clinical utilization of the international normalized ratio (INR). J. Clin. Lab. Anal. 2000; 14:101-114
WHO Technical Report Series, No. 610, 1977
Ian Jennings, PT/INR measurement for the management of VKA therapy, Stagowebinar.com, 3 October 2017
WHO Technical Report Series, No. 979, 2013
CLSI One-stage Prothrombin Time (PT) test and Activated Partial Thromboplastin Time (APTT) test; Approved guideline - second edition. CLSI document H47-A2 Wayne, PA: Clinical and Laboratory Standard Institute, 2008
Smith SA, Comp PC, Morrissey JH. Traces of factor VIIa modulate thromboplastin sensitivity to factors V, VII, X, and prothrombin. J Thromb Haemost. 2006;4(7):1553-1558.
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.
In today episode, our expert Pierre Bourgeat, will discuss about the Prothrombin time reagent characteristics with a specific focus on the ISI and the type of activators.
As usual, don’t forget to send any question you may have to [email protected], we will be glad to answer to it.
To learn more:
Listen to our podcast about MNPT determination: #7 How to determine the mean normal prothrombin time
View the Webinar of Ian Jenning on stagowebinar.com
Literature:
Lusher, J. Screening and diagnosis of coagulation disorders. Am. J. Obstet. Gynecol. 1986; 175:778-783
Riley, R., Rowe, D., & Fisher, L. Clinical utilization of the international normalized ratio (INR). J. Clin. Lab. Anal. 2000; 14:101-114
WHO Technical Report Series, No. 610, 1977
Ian Jennings, PT/INR measurement for the management of VKA therapy, Stagowebinar.com, 3 October 2017
WHO Technical Report Series, No. 979, 2013
CLSI One-stage Prothrombin Time (PT) test and Activated Partial Thromboplastin Time (APTT) test; Approved guideline - second edition. CLSI document H47-A2 Wayne, PA: Clinical and Laboratory Standard Institute, 2008
Smith SA, Comp PC, Morrissey JH. Traces of factor VIIa modulate thromboplastin sensitivity to factors V, VII, X, and prothrombin. J Thromb Haemost. 2006;4(7):1553-1558.
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.
More episodes of the podcast Ask Stago (english version)
S5E8 - Anti Xa and UFH monitoring
26/06/2025
S5E2 - Living with a rare blood clotting disorder, Hemophilia C: an interview with Joseph Bautista
07/05/2024
S5E1 - What is new in ISO 15189:2022?
02/04/2024
S4E4 - Limit of detection (LoD) and limit of quantitation (LoQ): what are we talking about?
23/05/2023
S4E3 - Women at work and Women in Science
07/03/2023
In God we trust